VACCITECH

Summary

Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 121 M

Avg. Deal Size£ 121 M

Market Context

Senior Management

Bill Enright
CEO

Sort

17 Mar 2021|United Kingdom|Biotechnology

Target: VACCITECH

Bidder: GILEAD SCIENCES

8 Service Providers

1 Target | 7 Bidder

22 Dealmakers

1 Target | 21 Bidder

£ 121 M

Value

Explore deals beyond your search with a free MergerLinks account.

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy